Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU

Journal of Virology

Volumn 77, Issue 7, 2003, Pages 3993-4003

  Burkhart, Michael Dominic ^a,b   Kayman, Samuel C ^a   He, Yuxian ^a   Pinter, Abraham ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PROLINE; PROTEIN MCAT 1; PROTEIN SU; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUSION; DISULFIDE BOND; HUMAN; HUMAN CELL; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RAT; VIRION; VIRUS ADSORPTION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BINDING SITES; CELL LINE; CRICETINAE; EPITOPE MAPPING; EPITOPES; FRIEND MURINE LEUKEMIA VIRUS; HUMANS; HYBRIDOMAS; LEUKEMIA VIRUS, MURINE; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, VIRUS; RETROVIRIDAE PROTEINS, ONCOGENIC; VIRAL ENVELOPE PROTEINS;

EID: 0037378503     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.7.3993-4003.2003     Document Type: Article

References (68)

1. Albritton, L. M., L. Tseng, D. Scadden, and J. M. Cunningham. 1989. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57:659-666.
2. Bae, Y., S. M. Kingsman, and A. J. Kingsman. 1997. Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J. Virol. 71:2092-2099.
3. Barnett, A. L., R. A. Davey, and J. M. Cunningham. 2001. Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proc. Natl. Acad. Sci. USA 98:4113-4118.
4. Burkhart, M. D. 2002. A study of retroviral neutralization by monoclonal antibodies specific for the murine leukemia virus envelope subunit SU. Ph.D. dissertation. New York University, New York, N.Y.
5. Burton, D., E. Saphire, and P. Parren. 2001. A model for neutralization of viruses based on antibody coating of the virion surface, p. 109-143. In D. Burton (ed.), Antibodies in viral infection. Springer-Verlag, Berlin, Germany.
6. Cheng-Mayer, C., C. Weiss, D. Seto, and J. A. Levy. 1989. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc. Natl. Acad. Sci. USA 86:8575-8579.
7. Chesebro, B., K. Wehrly, M. Cloyd, W. Britt, J. Portis, J. Collins, and J. Nishio. 1981. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology 112:131-144.
8. Davey, R. A., Y. Zuo, and J. M. Cunningham. 1999. Identification of a receptor-binding pocket on the envelope protein of Friend murine leukemia virus. J. Virol. 73:3758-3763.
9. Davey, R. A., C. A. Hamson, J. J. Healey, and J. M. Cunningham. 1997. In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J. Virol. 71:8096-8102.
10. DeLarco, J. E., and G. J. Todaro. 1976. Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein gp71. Cell 8:365-371.
11. Edwards, M. J., and N. J. Dimmock. 2001. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event. J. Virol. 75:10208-10218.
12. Evans, L. H., R. P. Morrison, F. G. Malik, J. Portis, and W. J. Britt. 1990. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64:6176-6183.
13. Fass, D., R. A. Davey, C. A. Hamson, P. S. Kim, J. M. Cunningham, and J. M. Berger. 1997. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277:1662-1666.
14. Fowler, A. K., D. R. Twardzik, C. D. Reed, O. S. Weislow, and A. Hellman. 1977. Binding characteristics of Rauscher leukemia virus envelope glycoprotein gp71 to murine lymphoid cells. J. Virol. 24:729-735.
15. Friend, C. 1957. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J. Exp. Med. 105:302-318.
16. Hammerling, U., A. Pinter, and P. V. O'Donnell. 1980. Monoclonal antibodies as a tool in research on oncogenic viruses, p. 255-256. In G. A. Beth (ed.), The role of viruses in human cancer. Elsevier, Amsterdam, The Netherlands.
17. Harlow, E., and D. Lane, 1988. Antibodies: a laboratory manual, p. 139-242. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
18. He, Y., W. J. Honnen, C. P. Krachmarov, M. Burkhart, S. C. Kayman, J. Corvalan, and A. Pinter. 2002. Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human IgG loci. J. Immunol. 169:595-605.
19. Heard, J. M., and O. Danos. 1991. An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor. J. Virol. 65:4026-4032.
20. Jakobovits, A. 1995. Production of fully human antibodies by transgenic mice. Curr. Opin. Biotechnol. 6:561-566.
21. Kai, K., K. Mitsuno, N. Goto, Y. Ami, S. Ando, and M. Kanoe. 1996. Factors affecting induction of neurological disorders in mice by paralysis-inducing Friend-related PVC viruses. J. Vet. Med. Sci. 58:285-290.
22. Kamps, C., Y. C. Lin, and P. K. Wong. 1991. Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuLV-TB. Virology 184:687-694.
23. Kayman, S. C., R. Kopelman, S. Projan, D. M. Kinney, and A. Pinter. 1991. Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein. J. Virol. 65:5323-5332.
24. Kayman, S. C., H. Park, M. Saxon, and A. Pinter. 1999. The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system. J. Virol. 73:1802-1808.
25. Kayman, S. C., Z. Wu, K. Revesz, H. Chen, R. Kopelman, and A. Pinter. 1994. Presentation of native epitopes in the V1/V2 anti V3 domains of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains. J. Virol. 68:400-410.
26. Kim, J., E. I. Closs, L. M. Albritton, and J. M. Cunningham. 1991. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 352:725-758.
27. Koch, W., G. Hunsmann, and R. Friedrich. 1983. Nucleotide sequence of the envelope gene of Friend murine leukemia virus. J. Virol. 45:1-9.
28. Krachmarov, C. P., S. C. Kayman, W. J. Honnen, O. Trochev, and A. Pinter. 2001. V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1. AIDS Res. Hum. Retrovir. 17:1737-1748.
29. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
30. Lavillette, D., B. Boson, S. J. Russell, and F.-L. Cosset. 2001. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J. Virol. 75:3685-3695.
31. Lavillette, D., A. Ruggieri, B. Boson, M. Maurice, and F.-L. Cosset. 2002. Relationship between SU subdomains that regulate the receplor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein. J. Virol. 76:9673-9685.
32. Lavillette, D., A. Ruggieri, S. J. Russell, and F.-L. Cosset. 2000. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments. J. Virol. 74:295-304.
33. Li, Z., A. Pinter, and S. C. Kayman. 1997. The critical N-linked glycan of murine leukemia virus envelope protein promotes both folding of the C-terminal domains of the precursor polyprotein and stability of the postcleavage envelope complex. J. Virol. 71:7012-7019.
34. Lostrom, M. E., S. R. Stone, M. Tam, W. N. Burnette, A. Pinter, and R. C. Nowinski. 1979. Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants of the p15(E) and gp70 envelope proteins. Virology 98:336-350.
35. Lowy, D. R., E. Rands, S. K. Chattopadhyay, C. F. Garon, and G. L. Hager. 1980. Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells. Proc. Natl. Acad. Sci. USA 77:614-618.
36. MacKrell, A. J., N. W. Soong, C. M. Curtis, and W. F. Anderson. 1996. Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J. Virol. 70:1768-1774.
37. McAtee, F. J., and J. L. Portis. 1985. Monoclonal antibodies specific for wild mouse neurotropic retrovirus: detection of comparable levels of virus replication in mouse strains susceptible and resistant to paralytic disease. J. Virol. 56:1018-1022.
38. McInerney, T., L. McLain, S. J. Armstrong, and N. J. Dimmock. 1997. A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event. Virology 233:313-326.
39. Mendez, M. J., L. L. Green, J. R. Corvalan, X. C. Jia, C. E. Maynard-Currie, X. D. Yang, M. L. Gallo, D. M. Louie, D. V. Lee, K. L. Erickson, J. Luna, C. M. Roy, H. Abderrahim, F. Kirschenbaum, M. Noguchi, D. H. Smith, A. Fukushima, J. F. Hales, S. Klapholz, M. H. Finer, et al. 1997. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat. Genet. 15:146-156.
40. Moloney, J. 1960. Biological studies on a lymphoid leukemia virus extracted from sarcoma 37. I. Origin and introductory observations. J. Natl. Cancer Inst. Monogr. 24:933.
41. Morgan, R. A., O. Nussbaum, D. D. Muenchau, L. Shu, L. Couture, and W. F. Anderson. 1993. Analysis of the functional and host range-determining regions of the murine ecotropic and amphotropic retrovirus envelope proteins. J. Virol. 67:4712-4721.
42. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
43. Niman, H. L., and J. H. Elder. 1982. Structural analysis of Rauscher virus gp70 using monoclonal antibodies: sites of antigenicity and P15(E) linkage. Virology 123:187-205.
44. Nowinski, R. C., R. Pickering, P. V. O'Donnell, A. Pinter, and U. Hammerling. 1981. Selective neutralization of ecotropic murine leukemia virus by monoclonal antibodies: localization of a site on the gp70 protein associated with ecotropism. Virology 111:84-92.
45. Orlik, O., J. Ban, J. Hlavaty, C. Altaner, R. Kettmann, D. Portetelle, and G. A. Splitter. 1997. Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1. J. Virol. 71.3263-3267.
46. Ott, D., R. Friedrich, and A. Rein. 1990. Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J. Virol. 64:757-766.
47. Parren, P. W. H. I., I. Mondor, D. Naniche, H. J. Ditzel, P. J. Klasse, D. R. Burton, and Q. J. Sattentau. 1998. Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity. J. Virol. 72:3512-3519.
48. IX antigen of murine leukemia virus: an analysis with monoclonal antibodies. Virology 112:450-460.
49. Pinter, A., T.-E. Chen, A. Lowy, N. G. Cortez, and S. Silagi. 1986. Ecotropic murine leukemia virus-induced fusion of murine cells. J. Virol. 57:1048-1054.
50. Pinter, A., and E. Fleissner. 1979. Characterization of oligomeric complexes of murine and feline leukemia virus envelope and core components formed upon cross-linking. J. Virol. 30:157-165.
51. Pinter, A., and W. J. Honnen. 1988. O-linked glycosylation of retroviral envelope gene products. J. Virol. 62:1016-1021.
52. Pinter, A., W. J. Honnen, S. C. Kayman, O. Troshev, and Z. Wu. 1998. Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120. Vaccine 16:1803-1811.
53. Pinter, A., W. J. Honnen, M. E. Racho, and S. A. Tilley. 1993. A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates. AIDS Res. Hum. Retrovir. 9:985-996.
54. Pinter, A., W. J. Honnen, S. A. Tilley, C. Bona, H. Zaghouani, M. K. Gorny, and S. Zolla-Pazner. 1989. Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 63:2674-2679.
55. Pinter, A., W. J. Honnen, J.-S. Tung, P. V. O'Donnell, and U. Hammerling. 1982. Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology 116:499-516.
56. Pinter, A., R. Kopelman, Z. Li, S. C. Kayman, and D. A. Sanders. 1997. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes. J. Virol. 71:8073-8077.
57. Portis, J. L., and F. J. McAtee. 1983. Monoclonal antibodies derived during graft-versus-host reaction. II. Antibodies detect unique determinants common to many MCF viruses. Virology 126:96-105.
58. Portis, J. L., F. J. McAtee, and M. W. Cloyd. 1982. Monoclonal antibodies to xenotropic and MCF murine leukemia viruses derived during the graft-versus-host reaction. Virology 118:181-190.
59. Pyle, S., D. J. Chabot, T. L. Miller, S. A. Serabyn, J. W. Bess, Jr., and L. O. Arthur. 1991. Large-scale purification of gp70 from Moloney murine leukemia virus. J. Virol. Methods 32:303-315.
60. Shibamura, S., K. Kai, T. Akatsuka, and T. Odaka. 1989. Biochemical and immunological characterization of murine leukemia viruses that are paralysis-inducing in rats. Jpn. J. Cancer Res. 80:24-30.
61. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
62. Stone, M. R., and R. C. Nowinski. 1980. Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies. Virology 100:370-381.
63. Stoye, J. P., and J. M. Coffin. 1987. The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination. J. Virol. 61:2659-2669.
64. IX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus. J. Exp. Med. 198:205.
65. Wang, N., T. Zhu, and D. D. Ho. 1995. Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype. J. Virol. 69:2708-2715.
66. Wu, B. W., P. M. Cannon, E. M. Gordon, F. L. Hall, and W. F. Anderson. 1998. Characterization of the proline-rich region of murine leukemia virus envelope protein. J. Virol. 72:5383-5391.
67. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-711.
68. Yu, H., N. Soong, and W. F. Anderson. 1995. Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J. Virol. 69:6557-6562.